At year-end 2017, we were involved in studies in 31 countries with over 169,000 patients, covering these therapeutic areas:



EU H2020 grant for unique HIT-Cystic Fibrosis project

The EU has granted 6.7 M€ from the Horizon 2020 research program to a broad collaborative group of researchers, doctors, pharmaceutical companies and patient representatives. Julius Clinical is one of the consortium partners and will be responsible for global Site Management, Monitoring, Data Man

read more

We are the research organisation that combines the latest scientific insights with operational excellence to develop innovative and credible solutions, enabling our clients to bring their treatments to the market faster.

read more